Online citations, reference lists, and bibliographies.
← Back to Search

Expression Of Peptidylarginine Deiminase Type 4 (PAD4) In Various Tumors

X. Chang, Jinxiang Han
Published 2006 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Peptidylarginine deiminase type 4 (PAD4/PADI4) posttranslationally converts peptidylarginine to citrulline, in a process known as citrullination. Evidence suggests that PAD4 plays an essential role in pathogenesis of rheumatoid arthritis (RA). RA synovium has many features in common with tumor tissues, including abnormal cell proliferation, extensive fibrin deposition, high coagulation activity, and extreme angiogenesis. The purpose of the present study was to investigate expression of PAD4 in various tumor tissues. Immunohistochemistry indicated that PAD4 had significant expression in many tumor tissues, especially various adenocarcinoma. Western blotting with anti PAD4 antibody and immunostaining with anti citrulline antibody confirmed the expression of the enzyme in these tumors. Furthermore, our immunohistochemistry also detected co‐location of PAD4 with cytokeratin (CK), a well‐known tumor marker for oncological study in many tumors. Western blot analysis also detected citrulline signals in CK extracted from the tumors. In addition, CK 8, 18, and 19 following in vitro citrullination resisted to the digestion of caspase. The results further confirm the expression of PAD4 in the tumors and support that PAD4 may contribute to the disrupted apoptosis of tumors by caspase‐mediated cleavage of CK. Double immunofluorescent labeling detected co‐location of PAD4 with CD34, a cell marker of heamatopoietic progenitor cells (HPC) in bone marrow and other normal tissues, as well as in some fibroblast‐like cells at stroma region of tumors, but not in the tumor cells. The findings imply that PAD4 is initially expressed in CD34+ cells of bone marrow and then distributed in derives of the multi‐potent progenitor cells in diverse tissues. The development of tumor cells expressing PAD4 is possibly associated with abnormal proliferation of CD34+ stem cells. © 2005 Wiley‐Liss, Inc.
This paper references
10.1093/AJCP/93.4.516
Malignant melanoma. Interaction with coagulation and fibrinolysis pathways in situ.
M. Wojtukiewicz (1990)
10.1016/S0304-3835(02)00258-6
Anticoagulants in cancer treatment: malignancy as a solid phase coagulopathy.
L. Zacharski (2002)
10.1046/j.1365-2559.2002.01387.x
Keratin expression in human tissues and neoplasms
P. Chu (2002)
10.1111/J.1432-0436.1989.TB00821.X
Expression of intermediate filament proteins in fetal and adult human lung tissues.
J. Broers (1989)
10.1042/BST0300201
Coagulation proteases and human cancer.
M. T. Sampson (2002)
Functional haplotypesof PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis
A Suzuki (2003)
10.1002/IJC.2910540514
Thrombin increases the metastatic potential of tumor cells
M. Wojtukiewicz (1993)
10.1111/j.1699-0463.1991.tb01288.x
Immunohistochemical localization of coagulation, fibrinolytic and antifibrinolytic markers in adenocarcinoma of the lung
B. Nakstad (1991)
10.1074/JBC.M103315200
Effect of Mutation and Phosphorylation of Type I Keratins on Their Caspase-mediated Degradation*
N. Ku (2001)
10.1007/S002920050181
[Cytokeratin expression of benign and malignant epithelial thyroid gland tumors. An immunohistologic study of 154 neoplasms using 8 different monoclonal cytokeratin antibodies].
S. Schroeder (1996)
10.1189/jlb.70.1.46
Immunocytochemical localization of peptidylarginine deiminase in human eosinophils and neutrophils
H. Asaga (2001)
10.1136/JCP.54.11.846
CD34 positive stromal cells in gastric adenocarcinomas.
H. Nakayama (2001)
Keratin modifications and solubility properties in epithelial cells and in vitro.
M. Omary (1998)
Fibrinogen deposition and macrophage-associated fibrin formation in malignant and nonmalignant lymphoid tissue.
V. Costantini (1992)
Cytokeratins as markers of differentiation in the diagnosis of epithelial tumors.
R. Moll (1998)
Fibrinogen-fibrin transformation in situ in renal cell carcinoma.
M. Wojtukiewicz (1990)
10.1093/RHEUMATOLOGY/KEH473
The inhibition of antithrombin by peptidylarginine deiminase 4 may contribute to pathogenesis of rheumatoid arthritis.
X. Chang (2005)
10.1186/ar1487
Inhibition of antithrombin by hyaluronic acid may be involved in the pathogenesis of rheumatoid arthritis
X. Chang (2005)
10.1093/RHEUMATOLOGY/KEH414
Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis.
X. Chang (2005)
10.1177/030089169808400310
Haemostatic Changes; Plasma Levels of Alpha2-Antiplasmin-Plasmin Complex and Thrombin-Antithrombin III Complex in Female Breast Cancer
Ö. Özyılkan (1998)
10.1038/sj.leu.2402620
CD34+ or CD34−: which is the more primitive?
M. Engelhardt (2002)
10.1002/path.1195
Steroid hormone receptor in pleural solitary fibrous tumours and CD34+ progenitor stromal cells
M. Bongiovanni (2002)
10.1159/000030148
The Versatility of Cytokeratins asTumor Markers
T. Stigbrand (2000)
10.1042/BST0300173
Mechanism of thrombin-induced angiogenesis.
M. Maragoudakis (2002)
10.1007/BF01611177
Distribution of cytokeratins, vimentin and desmoplakins in normal renal tissue, renal cell carcinomas and oncocytoma as revealed by immunofluorescence microscopy
A. Beham (2005)
10.1006/BBRC.1998.8148
Selective deimination of vimentin in calcium ionophore-induced apoptosis of mouse peritoneal macrophages.
H. Asaga (1998)
10.1074/jbc.274.34.23969
On the Mechanism of Thrombin-induced Angiogenesis
N. Tsopanoglou (1999)
10.1016/J.CLINBIOCHEM.2004.05.009
Clinical utility of cytokeratins as tumor markers.
V. Barak (2004)
10.1038/sj.cdd.4400988
Apoptosis and keratin intermediate filaments
R. Oshima (2002)
Effects of human bone marrow stroma on the growth of human tumor cells.
E. Strobel (1989)
The versatility of cytokeratins as tumormarkers
T. Stigbrand (2001)
10.1136/ARD.2003.012211
Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages.
E. Vossenaar (2004)
Use of monoclonal antibodies to keratin 7 in the differential diagnosis of adenocarcinomas.
F. Ramaekers (1990)
Serum antithrombin III and alpha-2-antiplasmin concentration in patients with lung carcinoma.
M. Dabrowska (1988)
10.1126/SCIENCE.6089338
Small cell carcinoma of the lung: macrophage-specific antigens suggest hemopoietic stem cell origin.
M. Ruff (1984)
10.1016/S1084952102001295
Cellular origin of hepatocellular carcinomas.
S. Sell (2002)
10.1007/s002920050181
Zytokeratinexpression benigner und maligner epithelialer Schilddrüsentumoren Eine immunhistologische Untersuchung an 154 Neoplasien unter Einsatz von 8 verschiedenen monoklonalen Zytokeratinantikörpern*
S. Schröder (1996)
10.14670/HH-19.59
The distribution and role of myofibroblasts and CD34-positive stromal cells in normal pancreas and various pancreatic lesions.
N. Kuroda (2004)
10.14670/HH-17.331
Lessons from disorders of epidermal differentiation-associated keratins.
A. Ishida-Yamamoto (2002)
10.1074/jbc.274.39.27786
Molecular Characterization of Peptidylarginine Deiminase in HL-60 Cells Induced by Retinoic Acid and 1α,25-Dihydroxyvitamin D3 *
K. Nakashima (1999)
Ca2+-dependent deimination-induced disassembly of intermediate filaments involves specific modification of the amino-terminal head domain.
M. Inagaki (1989)
Citrullination of fibronectin in synovial tissue of rheumatoid arthritis
X Chang (2005)
10.1378/CHEST.124.3_SUPPL.58S
Tissue factor, thrombin, and cancer.
F. Rickles (2003)
10.1002/BIES.10357
PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease
E. Vossenaar (2003)
Cytokeratins in different types of human lung cancer as monitored by chain-specific monoclonal antibodies.
J. Broers (1988)
10.1038/bjc.1996.161
Thrombin enhances the adhesion and migration of human colon adenocarcinoma cells via increased beta 3-integrin expression on the tumour cell surface and their inhibition by the snake venom peptide, rhodostomin.
H. S. Chiang (1996)
10.1093/RHEUMATOLOGY/KEI023
Citrullination of fibronectin in rheumatoid arthritis synovial tissue.
X. Chang (2005)
10.1002/jcb.10045
Stem cells: A minireview
K. Jackson (2002)
10.1055/S-0038-1651564
Increased plasma thrombomodulin in cancer patients.
A. Lindahl (1993)
10.1038/ng1206
Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis
A. Suzuki (2003)
10.1006/ABIO.1998.2925
Colorimetric determination of citrulline residues in proteins.
K. Sugawara (1998)
10.1186/ar1697
Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity
K. Lundberg (2005)
10.3892/OR.10.5.1313
CD34-positive stromal cells in primary lung carcinomas.
H. Nakayama (2003)
10.1016/S0304-3835(97)00310-8
Endothelial CD34 is suppressed in human malignancies: role of angiogenic factors.
S. Hellwig (1997)
10.1016/0959-8049(94)90766-8
Haemostatic changes; plasma levels of alpha2-antiplasmin-plasmin complex and thrombin-antithrombin III complex in female breast cancer.
O. Ozyilkan (1994)
10.1055/S-0037-1615356
Fibrin deposition in squamous cell carcinomas of the larynx and hypopharynx.
H. Bárdos (1998)



This paper is referenced by
10.1093/rheumatology/ken077
Synovial detection and autoantibody reactivity of processed citrullinated isoforms of vimentin in inflammatory arthritides.
K. Tilleman (2008)
10.1080/10408360701295623
Anti-Citrulline Antibodies in the Diagnosis and Prognosis of Rheumatoid Arthritis: Evolving Concepts
A. Raptopoulou (2007)
10.1093/intimm/dxr026
Specific expression of PAD4 and citrullinated proteins in lung cancer is not associated with anti-CCP antibody production.
Z. Baka (2011)
10.7150/IJBS.7.769
Investigating the Pathogenic Role of PADI4 in Oesophageal Cancer
X. Chang (2011)
10.3892/ol.2017.6001
B-cell specific Moloney leukemia virus insert site 1 and peptidyl arginine deiminase IV positively regulate carcinogenesis and progression of esophageal squamous cell carcinoma.
W. Wang (2017)
10.7314/APJCP.2015.16.17.7431
Progression of NETs Correlating with Tumor-Related Diseases.
Le-meng Zhang (2015)
10.1152/ajpgi.00435.2010
Suppression of colitis in mice by Cl-amidine: a novel peptidylarginine deiminase inhibitor.
A. Chumanevich (2011)
10.1007/978-1-4614-8317-5_14
Ongoing Studies of Deimination in Neurodegenerative Diseases Using the F95 Antibody
A. Nicholas (2014)
10.1016/j.jbspin.2012.01.008
Citrullination under physiological and pathological conditions.
Z. Baka (2012)
10.1158/1541-7786.MCR-19-0018
Endogenous PAD4 in Breast Cancer Cells Mediates Cancer Extracellular Chromatin Network Formation and Promotes Lung Metastasis
L. Shi (2020)
10.1016/j.bmcl.2018.01.026
Development of a fluorescent probe for detection of citrulline based on photo-induced electron transfer.
Kazuki Kunieda (2018)
10.1371/journal.pone.0053791
The Induction of microRNA-16 in Colon Cancer Cells by Protein Arginine Deiminase Inhibition Causes a p53-Dependent Cell Cycle Arrest
Xiangli Cui (2013)
10.4172/2155-9899.S6-006
Anti-Citrullinated Protein Antibodies as Novel Therapeutic Drugs in Rheumatoid Arthritis
R. G. Chirivi (2013)
10.1021/bi100363t
Substrate specificity and kinetic studies of PADs 1, 3, and 4 identify potent and selective inhibitors of protein arginine deiminase 3.
B. Knuckley (2010)
Protein-bound citrulline and homocitrulline in rheumatoid arthritis : confounding features arising from structural homology
S. Turunen (2014)
10.1016/j.dci.2019.103397
Extracellular vesicles from cod (Gadus morhua L.) mucus contain innate immune factors and deiminated protein cargo.
B. Magnadóttir (2019)
10.1016/B978-008045382-8.00170-2
Guanidine-modifying enzymes in the pentein superfamily
Thomas W. Linsky (2010)
10.3899/jrheum.140435
Inhibition of PCSK6 May Play a Protective Role in the Development of Rheumatoid Arthritis
Feifei Wang (2015)
10.1016/j.tem.2009.11.002
Protein arginine methylation in estrogen signaling and estrogen-related cancers
C. Teyssier (2010)
Immune response signatures of benzo{alpha}pyrene exposure in normal human mammary epithelial cells in the absence or presence of chlorophyllin.
Kaarthik John (2009)
10.1007/978-1-61779-376-9
Transcriptional Regulation
A. Vancura (2012)
10.7150/IJBS.6.454
Expression of Peptidylarginine Deiminase Type 4 in Ovarian Tumors
L. Wang (2010)
10.1111/jth.15003
Quantification of citrullinated histones: Development of an improved assay to reliably quantify nucleosomal H3Cit in human plasma
C. Thålin (2020)
10.1158/1541-7786.MCR-16-0034
Downregulation of the Deiminase PADI2 Is an Early Event in Colorectal Carcinogenesis and Indicates Poor Prognosis
Neus Cantariño (2016)
10.1155/2012/895343
Potential Role of Peptidylarginine Deiminase Enzymes and Protein Citrullination in Cancer Pathogenesis
Sunish Mohanan (2012)
10.1101/663427
NETosis proceeds by cytoskeleton and endomembrane disassembly and PAD4-mediated chromatin de-condensation and nuclear envelope rupture
Hawa Racine Thiam (2019)
10.1089/adt.2012.474
Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure.
M. Karsdal (2013)
of nuclear GSK 3 Q : 4 β activates TGF-β signaling and induces EMT in breast cancer cells
Sonja C. Stadlera (2013)
10.32469/10355/40185
Evaluation of autoimmune disease as a risk factor for lymphoma
B. Fowler (2013)
10.1093/BIOHORIZONS/HZW003
PAD4 inhibitors: potential sensitizers of tumour cells to TRAIL-induced apoptosis
Henna Khalid (2016)
10.1002/9781119250906.CH7
The Deimination of Arginine to Citrulline
Andrew J Creese (2016)
10.1007/s12013-012-9417-3
Decreased PADI4 mRNA Association with Global Hypomethylation in Hepatocellular Carcinoma During HBV Exposure
C. Zhang (2012)
See more
Semantic Scholar Logo Some data provided by SemanticScholar